PAHC PHIBRO ANIMAL HEALTH CORPcompanySEC Filings & Insider Trading Activity 2026
Latest PHIBRO ANIMAL HEALTH CORP (PAHC) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on August 27, 2025, a 10-Q quarterly report filed on February 4, 2026, an 8-K current report filed on April 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for PHIBRO ANIMAL HEALTH CORP (PAHC) (SEC CIK 1069899), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-06-30)
Business Overview
- • Core business model: Global animal health and mineral nutrition solutions for livestock and companion animals, marketing ~800 product lines across 90 countries
- • New acquisition: Zoetis medicated feed additive portfolio acquired for $297.5M, adding $208.2M net sales in FY25 and 6 manufacturing sites in US, Italy, China
Risk Factors
- • Cybersecurity attacks increasing in sophistication, with potential for material business impact
- • AI technology adoption risks, including compliance with privacy regulations and ethical use across enterprise
Management Discussion & Analysis
- • Revenue $1.296B, up 27% YoY from $1.018B; Animal Health best segment $963M, up 36% YoY; Performance Products worst $80.2M, up 19%
- • Adjusted net income $84.9M, up 76% YoY from $48.4M; adjusted diluted EPS $2.09 vs $1.19 prior year
AI 10-Q Quarterly Report AnalysisLatest 10-Q (2025-12-31)
Risk Factors
- • No new or materially changed risk factors reported since most recent 10-K filing
- • Regulatory compliance risk from evolving animal health product standards remains material, potentially impacting product approvals
Annual Reports Archive10-K
AI-powered analysis of PHIBRO ANIMAL HEALTH CORP (PAHC) 10-K annual reports filed with SEC EDGAR.
Quarterly Reports Archive10-Q
AI-powered analysis of PHIBRO ANIMAL HEALTH CORP (PAHC) 10-Q quarterly reports filed with SEC EDGAR.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $942.3M | $977.9M | $1.0B | $1.3B |
| Gross Profit | $285.4M | $298.2M | $313.1M | $399.9M |
| Operating Income | — | $71.8M | $53.3M | $110.5M |
| Net Income | — | $32.6M | $2.4M | $48.3M |
| Gross Margin | 30.3% | 30.5% | 30.8% | 30.9% |
| Op. Margin | — | 7.3% | 5.2% | 8.5% |
| Net Margin | — | 3.3% | 0.2% | 3.7% |
| Balance Sheet | ||||
| Total Assets | — | $971.4M | $982.2M | $1.4B |
| Equity | — | $282.5M | $256.6M | $285.7M |
| ROE | — | 11.5% | 0.9% | 16.9% |
Source: XBRL financial data from PHIBRO ANIMAL HEALTH CORP (PAHC) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Apr 30, 2026 | — | — | — |
8-K | Apr 27, 2026 | — | — | — |
8-K | Apr 14, 2026 | — | — | — |
10-Q | Feb 4, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 4, 2026 | — | — | |
8-K | Feb 3, 2026 | — | — | |
8-K | Dec 18, 2025 | — | — | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | — | |
10-K | Aug 27, 2025 | Jun 30, 2025 | Analysis | |
10-Q | May 7, 2025 | Mar 31, 2025 | — | |
10-Q | Feb 5, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 6, 2024 | Sep 30, 2024 | — | |
10-K | Aug 28, 2024 | Jun 30, 2024 | — | |
10-Q | May 8, 2024 | Mar 31, 2024 | — | |
10-Q | Feb 7, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 8, 2023 | Sep 30, 2023 | — | |
10-K | Aug 30, 2023 | Jun 30, 2023 | — | |
10-Q | Feb 8, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 9, 2022 | Sep 30, 2022 | — | |
10-K | Aug 24, 2022 | Jun 30, 2022 | — | |
10-Q | May 4, 2022 | Mar 31, 2022 | — | |
10-Q | Feb 9, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 2, 2021 | Sep 30, 2021 | — | |
10-K | Aug 25, 2021 | Jun 30, 2021 | — | |
10-Q | May 6, 2021 | Mar 31, 2021 | — |
Frequently Asked Questions
What are the latest PAHC SEC filings in 2026?
PHIBRO ANIMAL HEALTH CORP (PAHC) has filed a 10-K annual report on August 27, 2025, a 10-Q quarterly report on February 4, 2026, an 8-K current report on April 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did PAHC file its most recent 10-K annual report?
PHIBRO ANIMAL HEALTH CORP (PAHC) filed its most recent 10-K annual report on August 27, 2025. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view PAHC 10-Q quarterly reports?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s most recent 10-Q quarterly report was filed on February 4, 2026. SignalX displays every PAHC 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has PAHC filed recently?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s most recent 8-K was filed on April 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find PAHC insider trading activity (Form 4)?
SignalX aggregates every PAHC Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does PAHC file with the SEC?
PHIBRO ANIMAL HEALTH CORP (PAHC) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new PAHC filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for PHIBRO ANIMAL HEALTH CORP (PAHC).
What is PAHC's SEC CIK number?
PHIBRO ANIMAL HEALTH CORP (PAHC)'s SEC CIK (Central Index Key) number is 1069899. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1069899 to look up all PAHC filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find PAHC return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from PHIBRO ANIMAL HEALTH CORP (PAHC) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of PHIBRO ANIMAL HEALTH CORP SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 73+ filings.